← All trials
NCT03292809
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 19, 2017
- Primary completion
- Jul 31, 2018
- Completion date
- Dec 31, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 328
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Novaliq GmbHLead sponsor
- Novaliq GmbHStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.